Compare · MIR vs TMO
MIR vs TMO
Side-by-side comparison of Mirion Technologies Inc. (MIR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MIR and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $232.26B, about 63.4x MIR ($3.66B).
- Over the past year, MIR is down 29.8% and TMO is up 28.5% - TMO leads by 58.3 points.
- TMO has hit the wire 10 times in the past 4 weeks while MIR has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 10 for MIR).
- Company
- Mirion Technologies Inc.
- Thermo Fisher Scientific Inc
- Price
- $14.71+0.20%
- $628.06-0.13%
- Market cap
- $3.66B
- $232.26B
- 1M return
- -12.73%
- +12.31%
- 1Y return
- -29.79%
- +28.54%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 10
- Recent ratings
- 10
- 25
Mirion Technologies Inc.
Mirion Technologies, Inc. designs, manufactures, and delivers radiation detection, measurement, analysis, and monitoring products to nuclear power, medical, military, and homeland security markets. It offers personnel exposure monitoring and access control systems that include radiation detectors for handheld measurement; contamination and clearance products; wireless monitoring products; advanced detection and isotope identification products; and radiation area monitoring systems. The company also provides radiation tolerant cameras, high temperature imaging systems, and video image processing and accessories; and reactor control and protection, containment, effluent release monitoring, operational process monitoring, and area monitoring systems. In addition, it offers radiation monitoring services and dosimetry solutions for a range of applications; and nuclear sensing instrumentation and sealing systems that include in-core detectors, ex-core detectors, reactor neutron and gamma detector instruments, nuclear containment seals, and severe accident lines. Mirion Technologies, Inc. designs, manufactures, and delivers radiation detection, measurement, analysis, and monitoring products to nuclear power, medical, military, and homeland security markets. It offers personnel exposure monitoring and access control systems that include radiation detectors for handheld measurement; contamination and clearance products; wireless monitoring products; advanced detection and isotope identification products; and radiation area monitoring systems. The company also provides radiation tolerant cameras, high temperature imaging systems, and video image processing and accessories; and reactor control and protection, containment, effluent release monitoring, operational process monitoring, and area monitoring systems. In addition, it offers radiation monitoring services and dosimetry solutions for a range of applications; and nuclear sensing instrumentation and sealing systems that include in-core detectors, ex-core detectors, reactor neutron and gamma detector instruments, nuclear containment seals, and severe accident lines. It also offers service, such as measurement, installation, product support and repairs, and consulting services. The company serves customers in nuclear power plants, military and civil defense agencies, hospitals, universities, national labs, and other specialized industries. Mirion Technologies, Inc. was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in San Ramon, California with facilities in Europe, Asia, and North America. The company serves customers in nuclear power plants, military and civil defense agencies, hospitals, universities, national labs, and other specialized industries. Mirion Technologies, Inc. was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in San Ramon, California with facilities in Europe, Asia, and North America.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MIR
- SEC Form 10-Q filed by Mirion Technologies Inc.
- Mirion Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mirion Announces Second Quarter 2026 Financial Results
- Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2026
- Mirion Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Director Kingsley Lawrence D was granted 1,095 shares, increasing direct ownership by 2% to 72,525 units (SEC Form 4)
- SEC Form SD filed by Mirion Technologies Inc.
- Director Cascella Robert was granted 7,383 shares, increasing direct ownership by 14% to 60,801 units (SEC Form 4)
- Director Bockhorst Kenneth was granted 7,383 shares, increasing direct ownership by 11% to 77,258 units (SEC Form 4)
- Director Kingsley Lawrence D was granted 7,383 shares, increasing direct ownership by 12% to 71,430 units (SEC Form 4)
Latest TMO
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 20,000 shares at a strike of $309.63 and sold $12,561,823 worth of shares (20,000 units at $628.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $7,014,093 worth of shares (11,440 units at $613.12) and exercised 11,440 shares at a strike of $418.32, decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Executive Vice President Shafer Michael D exercised 25,500 shares at a strike of $370.58 and sold $15,300,000 worth of shares (25,500 units at $600.00) as part of a pre-agreed trading plan (SEC Form 4)
- Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
- VP & Chief Accounting Officer Holmes Joseph R. exercised 420 shares at a strike of $309.63 and sold $245,620 worth of shares (420 units at $584.81) (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $2,862,002 worth of shares (4,883 units at $586.12) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. exercised 5,850 shares at a strike of $309.63 and sold $3,393,000 worth of shares (5,850 units at $580.00), decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,616,967 worth of shares (15,000 units at $574.46) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,628,434 worth of shares (15,000 units at $575.23) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)